InnoSIGN
PrivateLast Round
Series A
Extension
Jul 26, 2022
Total Funding Raised
$10.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InnoSIGN operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Series A Extension round in July 2022.
InnoSIGN is a biotechnology company that provides mRNA-based pathway activity profiling technology to support diagnostics and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InnoSIGN Comparables
Compare InnoSIGN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AnyGenes | 77% | |
| DarwinHealth | 77% | |
| Metamorphosis Tx B.V. | 72% |
For institutional investors. Book with your work email.
InnoSIGN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 26, 2022 | ||||
| Series A | Mar 22, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InnoSIGN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Series A |
| Brabantse Ontwikkelings Maatschappij | Series A |
| Tech Coast Angels | Series A Extension |
| Thuja Capital | Series A |
| Casdin Capital | Series A |
| TCA Venture Group | Series A |
| Life Science Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 1144% MoM.
- Mar 22, 2022
$9.2M round led by Casdin Capital and Thuja Capital.
For institutional investors. Book with your work email.
InnoSIGN Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InnoSIGN's valuation, stock price, and market status.
Is InnoSIGN a public or private company?
InnoSIGN is a private company.
What is the current stock price of InnoSIGN?
InnoSIGN is a private company, so its shares have no public market price. Caplight tracks InnoSIGN's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InnoSIGN worth (valuation)?
Valuation information for InnoSIGN is not publicly available.
Can I buy InnoSIGN stock?
InnoSIGN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InnoSIGN's last funding round?
InnoSIGN's most recent funding round was Series A Extension on July 26, 2022.
Who are the main investors in InnoSIGN?
Key investors in InnoSIGN include Thuja Capital, Casdin Capital.
Will InnoSIGN IPO soon?
No public IPO plans have been announced for InnoSIGN.
How can I track InnoSIGN secondary market activity?
Caplight tracks bids, offers, and trades in InnoSIGN's shares on secondary markets.